CA2098029A1 - Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees - Google Patents

Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees

Info

Publication number
CA2098029A1
CA2098029A1 CA 2098029 CA2098029A CA2098029A1 CA 2098029 A1 CA2098029 A1 CA 2098029A1 CA 2098029 CA2098029 CA 2098029 CA 2098029 A CA2098029 A CA 2098029A CA 2098029 A1 CA2098029 A1 CA 2098029A1
Authority
CA
Canada
Prior art keywords
amino acid
acid sequence
retrovirus
retroviral
particles containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2098029
Other languages
English (en)
Other versions
CA2098029C (fr
Inventor
Benjamin Rovinski
Joel Haynes
Shi Xian Cao
Michel Henri Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Connaught Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Laboratories Ltd filed Critical Connaught Laboratories Ltd
Priority to CA 2098029 priority Critical patent/CA2098029C/fr
Publication of CA2098029A1 publication Critical patent/CA2098029A1/fr
Application granted granted Critical
Publication of CA2098029C publication Critical patent/CA2098029C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA 2098029 1993-06-09 1993-06-09 Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees Expired - Lifetime CA2098029C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2098029 CA2098029C (fr) 1993-06-09 1993-06-09 Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2098029 CA2098029C (fr) 1993-06-09 1993-06-09 Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees

Publications (2)

Publication Number Publication Date
CA2098029A1 true CA2098029A1 (fr) 1994-12-10
CA2098029C CA2098029C (fr) 2000-10-03

Family

ID=4151769

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2098029 Expired - Lifetime CA2098029C (fr) 1993-06-09 1993-06-09 Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees

Country Status (1)

Country Link
CA (1) CA2098029C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996030523A2 (fr) * 1995-03-31 1996-10-03 Hans Wolf Systeme de presentation d'antigenes fonde sur des particules similaires a des retrovirus

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996030523A2 (fr) * 1995-03-31 1996-10-03 Hans Wolf Systeme de presentation d'antigenes fonde sur des particules similaires a des retrovirus
WO1996030523A3 (fr) * 1995-03-31 1997-04-17 Hans Wolf Systeme de presentation d'antigenes fonde sur des particules similaires a des retrovirus

Also Published As

Publication number Publication date
CA2098029C (fr) 2000-10-03

Similar Documents

Publication Publication Date Title
CA2116764A1 (fr) Compositions de polypeptides du virus de l'hepatite c immunoreactives
AU1353295A (en) Peptides derived from a retrovirus of the HIV group, and their use
IE850983L (en) Polypeptides with an anticoagulant action
EP0336760A3 (fr) Protéines induisant la croissance des os
IE842210L (en) Vaccine
EP0370458A3 (fr) Antigènes à partir d'ADN synthétique dérivé du virus de l'immunodéficience humaine (HIV-1) recombinant
AU604033B2 (en) Concentrated aqueous microemulsions
CA2164818A1 (fr) Peptides synthetiques en tandem, vaccins contre le vih-1
EP0339504A3 (fr) Virus d'immunodéficience humaine (HIV) peptide env-codé capable de provoquer les anticorps inhibiteurs du HIV dans les mammifères
CA2005502A1 (fr) Analogues de la somatotrophine
IL70776A (en) Recombinant dna molecule encoding at least one polypeptide displaying the immunogenicity of at least one merozoite antigen or asexual blood stage antigen of p.falciparum,vectors comprising the dna molecule,host cells transformed thereby,immunogenic polypeptides produced by host cells and compositions containing the polypeptides
EP0307592A3 (fr) Analogues de l'inhibiteur de la trypsine pancréatique bovine, leur production et utilisation
CA2189882A1 (fr) Vaccins contre le papillomavirus
AU1179795A (en) Improved immunogenic compositions against human gastrin 17
CA2193210A1 (fr) Procede d'induction de reaction immunitaire au moyen d'un virus vivant de l'encephalite equine de venezuela exprimant un immunogene heterologue
EP1369427A3 (fr) Souches du retrovirus HIV-3 et leur utilisation
EP0140731A3 (fr) Facteurs natriurétiques
AU6806187A (en) Pseudorabies virus mutants minus g92 polypeptide
CA2042016A1 (fr) Peptides et polypeptides recombinants, acides nucleiques codant pour ceux-ci et utilisation de ces peptides et polypeptides dans le diagnostic de la tuberculose
CA2033175A1 (fr) Particules virales defectives autoformees et non autoreproductibles
CA2098029A1 (fr) Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees
AU4569293A (en) Anti-feline immunodeficiency virus (fiv) vaccines
EP0340170A3 (fr) Procédé pour la production des polypeptides
WO1997039029A3 (fr) Epitope antigenique du determinant a de l'antigene de surface de l'hepatite b et ses utilisations
DE59105636D1 (de) Expression von HIV1- und 2- Polypeptiden und deren Verwendung.

Legal Events

Date Code Title Description
EEER Examination request